Pfizer said no serious safety concerns related to the candidate vaccine have been reported. New Delhi: Major drugmaker Pfizer said Wednesday that its COVID-19 vaccine candidate was found to be 95 percent effective in the final analysis of the phase 3 trial, adding that it had the required two months …
Read More »Covid-19 Vaccine: Center May Not Get Pfizer Vaccines At All
The Center will deliberate whether to obtain the Pfizer vaccine against Covid-19, which requires a temperature of minus 70 degrees Celsius. And the storage requirement isn’t the only hurdle that worries the Covid-19 task force. The amount in which they will be available would not be enough for the Indian …
Read More »Moderna says its vaccine is 94.5% effective in preventing Covid-19
Moderna Inc said Monday that its experimental vaccine was 94.5% effective in preventing Covid-19 based on interim data from an advanced-stage clinical trial, becoming the second American company in a week to report results that far exceed expectations. Along with the Pfizer Inc vaccine, which has also been shown to …
Read More »The Covid vaccine would begin delivery “late this year, early next,” says one of the vaccine’s creators
The new Covid vaccine being developed by Pfizer and BioNTech would begin delivery “late this year, early next year” if everything continues to go well, one of its creators said Sunday. Last week, BioNTech and co-developers Pfizer said preliminary analysis showed that their vaccine could prevent more than 90 percent …
Read More »Live updates of the 234th day of the closure of the coronavirus in India | November 15, 2020
In a statement, the Health Ministry said that the proportion of active cases in total positive cases has further decreased to 5.48% in the country. The accumulated national figure is 93.05%. The total number of recovered cases stands at 81,63,572, and the gap between recovered cases and active cases, which …
Read More »First Lot of Sputnik V Vaccine to Arrive at Kanpur Medical College for Phase 2 and 3 Trials | India News
KANPUR: The first batch of Russia’s Sputnik V vaccine for Covid-19 is likely to arrive at Ganesh Shankar Vidyarthi Medical College in Kanpur next week, where phase 2 and phase 3 human clinical trials of the vaccine. The decision to conduct human clinical trials of the vaccine was made after …
Read More »First batch of Sputnik V from Russia to reach Kanpur for Phase 2, 3 tests
Kanpur: The first batch of Russia’s Sputnik V vaccine for COVID-19 is likely to arrive at Ganesh Shankar Vidyarthi Medical College in Kanpur next week, where phase 2 and phase 3 human clinical trials of the vaccine will take place. , according to a report. Speaking to the PTI news …
Read More »A million dollar question arises when lab executives sell shares amid the race for the Covid-19 vaccine
Pfizer, Moderna, Novavax: executives from several US laboratories developing COVID-19 Vaccines have recently raked in millions of dollars by selling shares in their companies, raising questions about the advisability of such a move amid a national health crisis. On the same day that pharmaceutical giant Pfizer announced preliminary data showing …
Read More »Crucial Facts About Covid-19 Vaccine and Treatment Just Days Away
By Riley Griffin Drug companies are beginning to unveil medical advances in the battle against coronavirus, in what one CEO described as “an incredible feat of disease science.” Over the next several weeks, we are likely to learn a lot more about how well these vaccines and treatments work. In …
Read More »Trump seems to acknowledge for the first time that Biden could succeed him
He also said that he expects a coronavirus vaccine to be available to the entire population starting in April. US President Donald Trump insisted on Friday that he would never put the United States in a coronavirus lockdown, but said “time will tell” if another administration takes office in January …
Read More »